financetom
Business
financetom
/
Business
/
Moderna ends development of CMV vaccine after trial failure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna ends development of CMV vaccine after trial failure
Oct 22, 2025 2:04 PM

Oct 22 (Reuters) - Moderna ( MRNA ) said on Wednesday it

will discontinue development of its experimental vaccine to

prevent cytomegalovirus, a common cause of birth defects, after

it failed to meet the main goal of a late-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved